References
Key articles
Pearle MS, Goldfarb DS, Assimos DG, et al. Medical management of kidney stones: AUA guideline. J Urol. 2014 Aug;192(2):316-24.Full text Abstract
European Association of Urology. Urolithiasis. Apr 2024 [internet publication].Full text
Assimos D, Krambeck A, Miller NL, et al. Surgical management of stones: American Urological Association/Endourological Society Guideline. 2016 [internet publication].Full text
Reference articles
1. Khan SR, Pearle MS, Robertson WG, et al. Kidney stones. Nat Rev Dis Primers. 2016 Feb 25;2:16008.Full text Abstract
2. Eisner BH, Goldfarb DS, Baum MA, et al. Evaluation and medical management of patients with cystine nephrolithiasis: a consensus statement. J Endourol. 2020 Nov;34(11):1103-10.Full text Abstract
3. Scales CD Jr, Smith AC, Hanley JM, et al. Prevalence of kidney stones in the United States. Eur Urol. 2012 Jul;62(1):160-5.Full text Abstract
4. Sorokin I, Mamoulakis C, Miyazawa K, et al. Epidemiology of stone disease across the world. World J Urol. 2017 Sep;35(9):1301-20. Abstract
5. Liu Y, Chen Y, Liao B, et al. Epidemiology of urolithiasis in Asia. Asian J Urol. 2018 Oct;5(4):205-14.Full text Abstract
6. Tasian GE, Ross ME, Song L, et al. Annual incidence of nephrolithiasis among children and adults in South Carolina from 1997 to 2012. Clin J Am Soc Nephrol. 2016 Mar 7;11(3):488-96.Full text Abstract
7. Romero V, Akpinar H, Assimos DG. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010 Spring;12(2-3):e86-96. Abstract
8. Fakheri RJ, Goldfarb DS. Ambient temperature as a contributor to kidney stone formation: implications of global warming. Kidney Int. 2011 Jun;79(11):1178-85.Full text Abstract
9. Liu J, Varghese BM, Hansen A, et al. Hot weather as a risk factor for kidney disease outcomes: a systematic review and meta-analysis of epidemiological evidence. Sci Total Environ. 2021 Dec 20;801:149806. Abstract
10. Curhan GC, Willett WC, Rimm EB, et al. Body size and risk of kidney stones. J Am Soc Nephrol. 1998 Sep;9(9):1645-52.Full text Abstract
11. Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005 Jan 26;293(4):455-62.Full text Abstract
12. Aune D, Mahamat-Saleh Y, Norat T, et al. Body fatness, diabetes, physical activity and risk of kidney stones: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol. 2018 Nov;33(11):1033-47.Full text Abstract
13. Worcester EM. Inhibitors of stone formation. Semin Nephrol. 1996 Sep;16(5):474-86. Abstract
14. Evan AP, Lingeman JE, Coe FL, et al. Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest. 2003 Mar;111(5):607-16.Full text Abstract
15. Agarwal MM, Singh SK, Mavuduru R, et al. Preventive fluid and dietary therapy for urolithiasis: an appraisal of strength, controversies and lacunae of current literature. Indian J Urol. 2011 Jul;27(3):310-9.Full text Abstract
16. Borghi L, Meschi T, Schianchi T, et al. Urine volume: stone risk factor and preventive measure. Nephron. 1999;8(suppl 1):31-7. Abstract
17. Pearle MS, Goldfarb DS, Assimos DG, et al. Medical management of kidney stones: AUA guideline. J Urol. 2014 Aug;192(2):316-24.Full text Abstract
18. Cheungpasitporn W, Rossetti S, Friend K, et al. Treatment effect, adherence, and safety of high fluid intake for the prevention of incident and recurrent kidney stones: a systematic review and meta-analysis. J Nephrol. 2016 Apr;29(2):211-9.Full text Abstract
19. Bao Y, Tu X, Wei Q. Water for preventing urinary stones. Cochrane Database Syst Rev. 2020 Feb 11;(2):CD004292.Full text Abstract
20. Curhan GC, Willett WC, Rimm EB, et al. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993 Mar 25;328(12):833-8.Full text Abstract
21. Curhan GC, Willett WC, Speizer FE, et al. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med. 1997 Apr 1;126(7):497-504. Abstract
22. Sakhaee K, Harvey JA, Padalino PK, et al. The potential role of salt abuse on the risk for kidney stone formation. J Urol. 1993 Aug;150(2 pt 1):310-2. Abstract
23. Soucie JM, Thun MJ, Coates RJ, et al. Demographic and geographic variability of kidney stones in the United States. Kidney Int. 1994 Sep;46(3):893-9. Abstract
24. Sarmina I, Spirnak JP, Resnick MI. Urinary lithiasis in the black population: an epidemiological study and review of the literature. J Urol. 1987 Jul;138(1):14-7. Abstract
25. Hiatt RA, Dales LG, Friedman GD, et al. Frequency of urolithiasis in a prepaid medical care program. Am J Epidemiol. 1982 Feb;115(2):255-65. Abstract
26. Stamatelou KK, Francis ME, Jones CA, et al. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003 May;63(5):1817-23. Abstract
27. Perletti G, Magri V, Ferraro PM, et al. Influence of dietary energy intake on nephrolithiasis - a meta-analysis of observational studies. Arch Ital Urol Androl. 2020 Apr 6;92(1):30-3.Full text Abstract
28. Rahman IA, Nusaly IF, Syahrir S, et al. Association between metabolic syndrome components and the risk of developing nephrolithiasis: a systematic review and bayesian meta-analysis. F1000Res. 2021 Feb 11:10:104.Full text Abstract
29. Geraghty R, Abdi A, Somani B, et al. Does chronic hyperglycaemia increase the risk of kidney stone disease? results from a systematic review and meta-analysis. BMJ Open. 2020 Jan 19;10(1):e032094.Full text Abstract
30. Wijarnpreecha K, Lou S, Panjawatanan P, et al. Nonalcoholic fatty liver disease and urolithiasis: a systematic review and meta-analysis. J Gastrointestin Liver Dis. 2018 Dec;27(4):427-32. Abstract
31. Jung H, Andonian S, Assimos D, et al. Urolithiasis: evaluation, dietary factors, and medical management: an update of the 2014 SIU-ICUD international consultation on stone disease. World J Urol. 2017 Sep;35(9):1331-40. Abstract
32. Gadiyar N, Geraghty RM, Premakumar Y, et al. Changes in urine composition and risk of kidney stone disease following bariatric surgery: a systematic review over last 2 decades. Curr Urol Rep. 2022 Nov;23(11):279-95. Abstract
33. Premakumar Y, Gadiyar N, Hameed BMZ, et al. Association of kidney stone disease (KSD) with primary gastrointestinal surgery: a systematic review over last 2 decades. Curr Urol Rep. 2021 May 24;22(6):34.Full text Abstract
34. Geraghty RM, Proietti S, Traxer O, et al. Worldwide impact of warmer seasons on the incidence of renal colic and kidney stone disease: evidence from a systematic review of literature. J Endourol. 2017 Aug;31(8):729-35. Abstract
35. Zhang Y, Long G, Ding B, et al. The impact of ambient temperature on the incidence of urolithiasis: a systematic review and meta-analysis. Scand J Work Environ Health. 2020 Mar 1;46(2):117-26.Full text Abstract
36. Policastro LJ, Saggi SJ, Goldfarb DS, et al. Personalized intervention in monogenic stone formers. J Urol. 2018 Mar;199(3):623-32.Full text Abstract
37. Atmoko W, Raharja PAR, Birowo P, et al. Genetic polymorphisms as prognostic factors for recurrent kidney stones: a systematic review and meta-analysis. PLoS One. 2021 May 6;16(5):e0251235.Full text Abstract
38. Daudon M, Frochot V, Bazin D, et al. Drug-induced kidney stones and crystalline nephropathy: pathophysiology, prevention and treatment. Drugs. 2018 Feb;78(2):163-201. Abstract
39. Tasian GE, Jemielita T, Goldfarb DS, et al. Oral antibiotic exposure and kidney stone disease. J Am Soc Nephrol. 2018 Jun;29(6):1731-40. Abstract
40. Asoudeh F, Talebi S, Jayedi A, et al. Associations of total protein or animal protein intake and animal protein sources with risk of kidney stones: a systematic review and dose-response meta-analysis. Adv Nutr. 2022 Jun 1;13(3):821-32.Full text Abstract
41. Borghi L, Schianchi T, Meschi T, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002 Jan 10;346(2):77-84.Full text Abstract
42. Ferraro PM, Mandel EI, Curhan GC, et al. Dietary protein and potassium, diet-dependent net acid load, and risk of incident kidney stones. Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1834-44.Full text Abstract
43. Dai JC, Pearle MS. Diet and stone disease in 2022. J Clin Med. 2022 Aug 13;11(16):4740.Full text Abstract
44. Jiang K, Tang K, Liu H, et al. Ascorbic Acid supplements and kidney stones incidence among men and women: a systematic review and meta-analysis. Urol J. 2019 May 5;16(2):115-20.Full text Abstract
45. Thomas LD, Elinder CG, Tiselius HG, et al. Ascorbic acid supplements and kidney stone incidence among men: a prospective study. JAMA Intern Med. 2013 Mar 11;173(5):386-8. Abstract
46. Lin BB, Lin ME, Huang RH, et al. Dietary and lifestyle factors for primary prevention of nephrolithiasis: a systematic review and meta-analysis. BMC Nephrol. 2020 Jul 11;21(1):267.Full text Abstract
47. Wang Z, Zhang Y, Wei W. Effect of dietary treatment and fluid intake on the prevention of recurrent calcium stones and changes in urine composition: a meta-analysis and systematic review. PLoS One. 2021 Apr 19;16(4):e0250257.Full text Abstract
48. European Association of Urology. Urolithiasis. Apr 2024 [internet publication].Full text
49. Minotti B, Treglia G, Pascale M, et al. Prevalence of microhematuria in renal colic and urolithiasis: a systematic review and meta-analysis. BMC Urol. 2020 Aug 8;20(1):119.Full text Abstract
50. Mefford JM, Tungate RM, Amini L, et al. A comparison of urolithiasis in the presence and absence of microscopic hematuria in the emergency department. West J Emerg Med. 2017 Jun;18(4):775-9.Full text Abstract
51. Ganesan C, Weia B, Thomas IC, et al. Analysis of primary hyperparathyroidism screening among US veterans with kidney stones. JAMA Surg. 2020 Sep 1;155(9):861-8.Full text Abstract
52. American College of Radiology. ACR appropriateness criteria: acute onset flank pain-suspicion of stone disease (urolithiasis). 2023 [internet publication].Full text
53. Fulgham PF, Assimos DG, Pearle MS, et al. Clinical effectiveness protocols for imaging in the management of ureteral calculous disease: AUA Technology Assessment. J Urol. 2013 Apr;189(4):1203-13.Full text Abstract
54. Ripollés T, Agramunt M, Errando J, et al. Suspected ureteral colic: plain film and sonography vs unenhanced helical CT. A prospective study in 66 patients. Eur Radiol. 2004 Jan;14(1):129-36. Abstract
55. Gorelik U, Ulish Y, Yagil Y. The use of standard imaging techniques and their diagnostic value in the workup of renal colic in the setting of intractable flank pain. Urology. 1996 May;47(5):637-42. Abstract
56. Dalla Palma L, Stacul F, Bazzocchi M, et al. Ultrasonography and plain film versus intravenous urography in ureteric colic. Clin Radiol. 1993 May;47(5):333-6. Abstract
57. Smith-Bindman R, Aubin C, Bailitz J, et al. Ultrasonography versus computed tomography for suspected nephrolithiasis. N Engl J Med. 2014 Sep 18;371(12):1100-10.Full text Abstract
58. Metzler IS, Smith-Bindman R, Moghadassi M, et al. Emergency department imaging modality effect on surgical management of nephrolithiasis: a multicenter, randomized clinical trial. J Urol. 2017 Mar;197(3 pt 1):710-4.Full text Abstract
59. Wong C, Teitge B, Ross M, et al. The accuracy and prognostic value of point-of-care ultrasound for nephrolithiasis in the emergency department: a systematic review and meta-analysis. Acad Emerg Med. 2018 Jun;25(6):684-98.Full text Abstract
60. ACOG Committee on Obstetric Practice. Committee opinion no. 723: Guidelines for diagnostic imaging during pregnancy and lactation. Obstet Gynecol. 2017 Oct;130(4):e210-6.Full text Abstract
61. Valovska MI, Pais VM Jr. Contemporary best practice urolithiasis in pregnancy. Ther Adv Urol. 2018 Apr;10(4):127-38.Full text Abstract
62. Grivas N, Thomas K, Drake T, et al. Imaging modalities and treatment of paediatric upper tract urolithiasis: a systematic review and update on behalf of the EAU urolithiasis guidelines panel. J Pediatr Urol. 2020 Oct;16(5):612-24. Abstract
63. McGrath TA, Frank RA, Schieda N, et al. Diagnostic accuracy of dual-energy computed tomography (DECT) to differentiate uric acid from non-uric acid calculi: systematic review and meta-analysis. Eur Radiol. 2020 May;30(5):2791-801. Abstract
64. Worcester EM, Coe FL. Clinical practice. Calcium kidney stones. N Engl J Med. 2010 Sep 2;363(10):954-63.Full text Abstract
65. Uribarri J, Oh MS, Carroll HJ. The first kidney stone. Ann Intern Med. 1989 Dec 15;111(12):1006-9. Abstract
66. Moore CL, Daniels B, Ghita M, et al. Accuracy of reduced-dose computed tomography for ureteral stones in emergency department patients. Ann Emerg Med. 2015 Feb;65(2):189-98.Full text Abstract
67. Bhojani N, Bjazevic J, Wallace B, et al. Update - Canadian Urological Association guideline: evaluation and medical management of kidney stones. Can Urol Assoc J. 2022 Jun;16(6):175-88.Full text Abstract
68. Barocas DA, Boorjian SA, Alvarez RD, et al. Microhematuria: AUA/SUFU guideline. J Urol. 2020 Oct;204(4):778-86.Full text Abstract
69. American College of Radiology. ACR appropriateness criteria: hematuria. 2019 [internet publication].Full text
70. American College of Radiology. ACR appropriateness criteria: hematuria - child. 2018 [internet publication].Full text
71. American College of Radiology. ACR appropriateness criteria: acute nonlocalized abdominal pain. 2018 [internet publication].Full text
72. Assimos D, Krambeck A, Miller NL, et al. Surgical management of stones: American Urological Association/Endourological Society Guideline. 2016 [internet publication].Full text
73. Sammon JD, Ghani KR, Karakiewicz PI, et al. Temporal trends, practice patterns, and treatment outcomes for infected upper urinary tract stones in the United States. Eur Urol. 2013 Jul;64(1):85-92. Abstract
74. Dreger NM, Degener S, Ahmad-Nejad P, et al. Urosepsis--etiology, diagnosis, and treatment. Dtsch Arztebl Int. 2015 Dec 4;112(49):837-47.Full text Abstract
75. Pathan SA, Mitra B, Cameron PA. A systematic review and meta-analysis comparing the efficacy of nonsteroidal anti-inflammatory drugs, opioids, and paracetamol in the treatment of acute renal colic. Eur Urol. 2018 Apr;73(4):583-95. Abstract
76. Afshar K, Jafari S, Marks AJ, et al. Nonsteroidal anti-inflammatory drugs (NSAIDs) and non-opioids for acute renal colic. Cochrane Database Syst Rev. 2015 Jun 29;(6):CD006027.Full text Abstract
77. National Institute for Health and Care Excellence. Renal and ureteric stones: assessment and management. Jan 2019 [internet publication].Full text
78. Davenport K, Waine E. The role of non-steroidal anti-inflammatory drugs in renal colic. Pharmaceuticals (Basel). 2010 Apr 28;3(5):1304-10.Full text Abstract
79. Gu HY, Luo J, Wu JY, et al. Increasing nonsteroidal anti-inflammatory drugs and reducing opioids or paracetamol in the management of acute renal colic: based on three-stage study design of network meta-analysis of randomized controlled trials. Front Pharmacol. 2019 Feb 22:10:96.Full text Abstract
80. American College of Emergency Physicians. Optimizing the treatment of acute pain in the emergency department. Ann Emerg Med. 2017 Sep;70(3):446-8.Full text Abstract
81. Keller D, Seamon J, Jones JS. BET 2: usefulness of IV lidocaine in the treatment of renal colic. Emerg Med J. 2016 Nov;33(11):825-6. Abstract
82. Motov S, Drapkin J, Butt M, et al. Pain management of renal colic in the emergency department with intravenous lidocaine. Am J Emerg Med. 2018 Oct;36(10):1862-4. Abstract
83. Fakhr Yasseri A, Saatchi M, Khatami F, et al. The prevalence of renal stones and outcomes of conservative treatment in kidney transplantation: a systematic review and meta-analysis. Urol J. 2021 May 8;18(3):252-8.Full text Abstract
84. Jendeberg J, Geijer H, Alshamari M, et al. Size matters: the width and location of a ureteral stone accurately predict the chance of spontaneous passage. Eur Radiol. 2017 Nov;27(11):4775-85.Full text Abstract
85. Eisner BH, Goldfarb DS, Pareek G. Pharmacologic treatment of kidney stone disease. Urol Clin North Am. 2013 Feb;40(1):21-30. Abstract
86. Campschroer T, Zhu X, Vernooij RW, et al. Alpha-blockers as medical expulsive therapy for ureteral stones. Cochrane Database Syst Rev. 2018 Apr 5;(4):CD008509.Full text Abstract
87. Sridharan K, Sivaramakrishnan G. Efficacy and safety of alpha blockers in medical expulsive therapy for ureteral stones: a mixed treatment network meta-analysis and trial sequential analysis of randomized controlled clinical trials. Expert Rev Clin Pharmacol. 2018 Mar;11(3):291-307. Abstract
88. Meltzer AC, Burrows PK, Wolfson AB, et al. Effect of tamsulosin on passage of symptomatic ureteral stones: a randomized clinical trial. JAMA Intern Med. 2018 Aug 1;178(8):1051-7.Full text Abstract
89. Hollingsworth JM, Canales BK, Rogers MA, et al. Alpha blockers for treatment of ureteric stones: systematic review and meta-analysis. BMJ. 2016 Dec 1;355:i6112.Full text Abstract
90. Wang RC, Smith-Bindman R, Whitaker E, et al. Effect of tamsulosin on stone passage for ureteral stones: a systematic review and meta-analysis. Ann Emerg Med. 2017 Mar;69(3):353-61.e3. Abstract
91. Aboumarzouk OM, Jones P, Amer T, et al. What is the role of alpha-blockers for medical expulsive therapy? Results rrom a meta-analysis of 60 randomized trials and over 9500 patients. Urology. 2018 Sep;119:5-16.Full text Abstract
92. Hsu YP, Hsu CW, Bai CH, et al. Silodosin versus tamsulosin for medical expulsive treatment of ureteral stones: aA systematic review and meta-analysis. PLoS One. 2018 Aug 28;13(8):e0203035.Full text Abstract
93. Oestreich MC, Vernooij RW, Sathianathen NJ, et al. Alpha-blockers after shock wave lithotripsy for renal or ureteral stones in adults. Cochrane Database Syst Rev. 2020 Nov 12;(11):CD013393.Full text Abstract
94. Micali S, Grande M, Sighinolfi MC, et al. Medical therapy of urolithiasis. J Endourol. 2006 Nov;20(11):841-7. Abstract
95. Lerner LB, McVary KT, Barry MJ, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE PART I-Initial work-up and medical management. J Urol. 2021 Oct;206(4):806-17.Full text Abstract
96. Lingeman JE, Matlaga BR, Evan AP. Surgical management of upper urinary tract calculi. In: Wein AJ, Kavoussi LR, Novick AC, et al., eds. Campbell's urology. 9th ed. Philadelphia, PA: Saunders Elsevier; 2007:1431-507.
97. Mantica G, Balzarini F, Chierigo F, et al. The fight between PCNL, laparoscopic and robotic pyelolithotomy: do we have a winner? A systematic review and meta-analysis. Minerva Urol Nephrol. 2022 Apr;74(2):169-77.Full text Abstract
98. Geraghty R, Burr J, Simmonds N, et al. Shock wave lithotripsy outcomes for lower pole and non-lower pole stones from a university teaching hospital: parallel group comparison during the same time period. Urol Ann. 2015 Jan-Mar;7(1):46-8.Full text Abstract
99. Junbo L, Yugen L, Guo J, et al. Retrograde intrarenal surgery vs. percutaneous nephrolithotomy vs. extracorporeal shock wave lithotripsy for lower pole renal stones 10-20 mm : a meta-analysis and systematic review. Urol J. 2019 May 5;16(2):97-106.Full text Abstract
100. Bozzini G, Verze P, Arcaniolo D, et al. A prospective randomized comparison among SWL, PCNL and RIRS for lower calyceal stones less than 2 cm: a multicenter experience : a better understanding on the treatment options for lower pole stones. World J Urol. 2017 Dec;35(12):1967-75. Abstract
101. Kachel TA, Vijan SR, Dretler SP. Endourological experience with cystine calculi and a treatment algorithm. J Urol. 1991 Jan;145(1):25-8. Abstract
102. Grasso M, Ficazzola M. Retrograde ureteropyeloscopy for lower pole caliceal calculi. J Urol. 1999 Dec;162(6):1904-8. Abstract
103. Aboumarzouk OM, Monga M, Kata SG, et al. Flexible ureteroscopy and laser lithotripsy for stones >2 cm: a systematic review and meta-analysis. J Endourol. 2012 Oct;26(10):1257-63. Abstract
104. Barone B, Crocetto F, Vitale R, et al. Retrograde intra renal surgery versus percutaneous nephrolithotomy for renal stones >2 cm. A systematic review and meta-analysis. Minerva Urol Nefrol. 2020 Aug;72(4):441-50.Full text Abstract
105. Soderberg L, Ergun O, Ding M, et al. Percutaneous nephrolithotomy versus retrograde intrarenal surgery for treatment of renal stones in adults. Cochrane Database Syst Rev. 2023 Nov 13;(11):CD013445.Full text Abstract
106. Ordonez M, Hwang EC, Borofsky M, et al. Ureteral stent versus no ureteral stent for ureteroscopy in the management of renal and ureteral calculi. Cochrane Database Syst Rev. 2019 Feb 6;2:CD012703.Full text Abstract
107. Zhu Y, Duijvesz D, Rovers MM, et al. Alpha-blockers to assist stone clearance after extracorporeal shock wave lithotripsy: a meta-analysis. BJU Int. 2010 Jul;106(2):256-61. Abstract
108. Wang Z, Bai Y, Wang J. Effects of diuretic administration on outcomes of extracorporeal shockwave lithotripsy: a systematic review and meta-analysis. PLoS One. 2020 Mar 5;15(3):e0230059.Full text Abstract
109. Liu LR, Li QJ, Wei Q, et al. Percussion, diuresis, and inversion therapy for the passage of lower pole kidney stones following shock wave lithotripsy. Cochrane Database Syst Rev. 2013 Dec 8;(12):CD008569.Full text Abstract
110. Dong L, Wang F, Chen H, et al. The efficacy and safety of diuretics on extracorporeal shockwave lithotripsy treatment of urolithiasis: A systematic review and meta analysis. Medicine (Baltimore). 2020 Jun 19;99(25):e20602.Full text Abstract
111. Reynolds LF, Kroczak T, Pace KT. Indications and contraindications for shock wave lithotripsy and how to improve outcomes. Asian J Urol. 2018 Oct;5(4):256-63.Full text Abstract
112. Davis NF, Quinlan MR, Browne C, et al. Single-use flexible ureteropyeloscopy: a systematic review. World J Urol. 2018 Apr;36(4):529-36.Full text Abstract
113. Fahmy O, Shsm H, Lee C, et al. Impact of preoperative stenting on the outcome of flexible ureterorenoscopy for upper urinary tract urolithiasis: a systematic review and meta-analysis. Urol Int. 2022;106(7):679-87. Abstract
114. Chen H, Pan Y, Xiao M, et al. The outcomes of pre-stenting on renal and ureteral stones: a meta-analysis. Urol Int. 2022;106(5):495-503. Abstract
115. Law YXT, Teoh JYC, Castellani D, et al. Role of pre-operative ureteral stent on outcomes of retrograde intra-renal surgery (RIRS): systematic review and meta-analysis of 3831 patients and comparison of Asian and non-Asian cohorts. World J Urol. 2022 Jun;40(6):1377-89. Abstract
116. Dell'Atti L, Papa S. Ten-year experience in the management of distal ureteral stones greater than 10 mm in size. G Chir. 2016 Jan-Feb;37(1):27-30.Full text Abstract
117. Cui X, Ji F, Yan H, et al. Comparison between extracorporeal shock wave lithotripsy and ureteroscopic lithotripsy for treating large proximal ureteral stones: a meta-analysis. Urology. 2015 Apr;85(4):748-56. Abstract
118. Drake T, Grivas N, Dabestani S, et al. What are the benefits and harms of ureteroscopy compared with shock-wave lithotripsy in the treatment of upper ureteral stones? A systematic review. Eur Urol. 2017 Nov;72(5):772-86. Abstract
119. Aboumarzouk OM, Kata SG, Keeley FX, et al. Extracorporeal shock wave lithotripsy (ESWL) versus ureteroscopic management for ureteric calculi. Cochrane Database Syst Rev. 2012 May 16;(5):CD006029.Full text Abstract
120. Maheshwari PN, Oswal AT, Andankar M, et al. Is antegrade ureteroscopy better than retrograde ureteroscopy for impacted large upper ureteral calculi? J Endourol. 1999 Jul-Aug;13(6):441-4. Abstract
121. el-Nahas AR, Eraky I, el-Assmy AM, et al. Percutaneous treatment of large upper tract stones after urinary diversion. Urology. 2006 Sep;68(3):500-4. Abstract
122. Wang Q, Guo J, Hu H, et al. Rigid ureteroscopic lithotripsy versus percutaneous nephrolithotomy for large proximal ureteral stones: a meta-analysis. PLoS One. 2017 Feb 9;12(2):e0171478.Full text Abstract
123. Zeng G, Zhong W, Pearle M, et al. European Association of Urology Section of Urolithiasis and International Alliance of Urolithiasis Joint Consensus on percutaneous nephrolithotomy. Eur Urol Focus. 2022 Mar;8(2):588-97. Abstract
124. Breda A, Territo A, Scoffone C, et al. The evaluation of radiologic methods for access guidance in percutaneous nephrolithotomy: a systematic review of the literature. Scand J Urol. 2018 Apr;52(2):81-6.Full text Abstract
125. Lingeman JE, Coury TA, Newman DM, et al. Comparison of results and morbidity of percutaneous nephrostolithotomy and extracorporeal shock wave lithotripsy. J Urol. 1987 Sep;138(3):485-90. Abstract
126. Dorantes-Carrillo LA, Basulto-Martínez M, Suárez-Ibarrola R, et al. Retrograde intrarenal surgery versus miniaturized percutaneous nephrolithotomy for kidney stones >1cm: a systematic review and meta-analysis of randomized trials. Eur Urol Focus. 2022 Jan;8(1):259-70. Abstract
127. Zhang B, Hu Y, Gao J, et al. Micropercutaneous versus retrograde intrarenal surgery for the management of moderately sized kidney stones: a systematic review and meta-analysis. Urol Int. 2020;104(1-2):94-105. Abstract
128. Güler A, Erbin A, Ucpinar B, et al. Comparison of miniaturized percutaneous nephrolithotomy and standard percutaneous nephrolithotomy for the treatment of large kidney stones: a randomized prospective study. Urolithiasis. 2019 Jun;47(3):289-95. Abstract
129. Kandemir E, Savun M, Sezer A, et al. Comparison of miniaturized percutaneous nephrolithotomy and standard percutaneous nephrolithotomy in secondary patients: a randomized prospective study. J Endourol. 2020 Jan;34(1):26-32. Abstract
130. Feng D, Hu X, Tang Y, et al. The efficacy and safety of miniaturized percutaneous nephrolithotomy versus standard percutaneous nephrolithotomy: a systematic review and meta-analysis of randomized controlled trials. Investig Clin Urol. 2020 Mar;61(2):115-26.Full text Abstract
131. Semins MJ, Matlaga BR. Kidney stones during pregnancy. Nat Rev Urol. 2014 Mar;11(3):163-8. Abstract
132. Burgess KL, Gettman MT, Rangel LJ, et al. Diagnosis of urolithiasis and rate of spontaneous passage during pregnancy. J Urol. 2011 Dec;186(6):2280-4. Abstract
133. Zhou Q, Chen WQ, Xie XS, et al. Maternal and neonatal outcomes of pregnancy complicated by urolithiasis: a systematic review and meta-analysis. J Nephrol. 2021 Oct;34(5):1569-80. Abstract
134. Semins MJ, Trock BJ, Matlaga BR. The safety of ureteroscopy during pregnancy: a systematic review and meta-analysis. J Urol. 2009 Jan;181(1):139-43. Abstract
135. Gambaro G, Croppi E, Coe F, et al; Consensus Conference Group. Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol. 2016 Dec;29(6):715-34.Full text Abstract
136. US Food and Drug Administration. FDA adds boxed warning for increased risk of death with gout medicine Uloric (febuxostat). Feb 2019 [internet publication].Full text
137. White WB, Saag KG, Becker MA, et al. Cardiovascular safety of febuxostat or allopurinol in patients with gout. N Engl J Med. 2018 Mar 12;378(13):1200-10.Full text Abstract
138. Medicines and Healthcare products Regulatory Agency. Febuxostat (Adenuric): increased risk of cardiovascular death and all-cause mortality in clinical trial in patients with a history of major cardiovascular disease. Jul 2019 [internet publication].Full text
139. Phillips R, Hanchanale VS, Myatt A, et al. Citrate salts for preventing and treating calcium containing kidney stones in adults. Cochrane Database Syst Rev. 2015 Oct 6;(10):CD010057.Full text Abstract
140. Kern A, Grimsby G, Mayo H, et al. Medical and dietary interventions for preventing recurrent urinary stones in children. Cochrane Database Syst Rev. 2017 Nov 9;(11):CD011252.Full text Abstract
141. Barreto L, Jung JH, Abdelrahim A, et al. Medical and surgical interventions for the treatment of urinary stones in children. Cochrane Database Syst Rev. 2019 Oct 9;10:CD010784.Full text Abstract
142. El Said NO, El Wakeel L, Kamal KM, et al. Alfuzosin treatment improves the rate and time for stone expulsion in patients with distal uretral stones: a prospective randomized controlled study. Pharmacotherapy. 2015 May;35(5):470-6. Abstract
143. Sur RL, Shore N, L'Esperance J. Silodosin to facilitate passage of ureteral stones: a multi-institutional, randomized, double-blinded, placebo-controlled trial. Eur Urol. 2015 May;67(5):959-64. Abstract
144. Yang D, Wu J, Yuan H, et al. The efficacy and safety of silodosin for the treatment of ureteral stones: a systematic review and meta-analysis. BMC Urol. 2016 May 27;16(1):23.Full text Abstract
145. Escribano J, Balaguer A, Roqué i Figuls M, et al. Dietary interventions for preventing complications in idiopathic hypercalciuria. Cochrane Database Syst Rev. 2014 Feb 11;(2):CD006022.Full text Abstract
146. Goldfarb DS, MacDonald PA, Gunawardhana L, et al. Randomized controlled trial of febuxostat versus allopurinol or placebo in individuals with higher urinary uric acid excretion and calcium stones. Clin J Am Soc Nephrol. 2013 Nov;8(11):1960-7.Full text Abstract
147. Worcester EM. Stones from bowel disease. Endocrinol Metab Clin North Am. 2002 Dec;31(4):979-99. Abstract
148. Pak CY, Fuller C, Sakhaee K, et al. Management of cystine nephrolithiasis with alpha-mercaptopropionylglycine. J Urol. 1986 Nov;136(5):1003-8. Abstract
149. Harper JD, Lingeman JE, Sweet RM, et al. Fragmentation of stones by burst wave lithotripsy in the first 19 humans. J Urol. 2022 May;207(5):1067-76.Full text Abstract
150. Razi A, Farrokhi E, Lotfabadi P, et al. Dexamethasone and ketorolac compare with ketorolac alone in acute renal colic: a randomized clinical trial. Am J Emerg Med. 2022 Aug;58:245-50. Abstract
151. Garrelfs SF, Frishberg Y, Hulton SA, et al. Lumasiran, an RNAi therapeutic for primary hyperoxaluria type 1. N Engl J Med. 2021 Apr 1;384(13):1216-26.Full text Abstract
152. Lee JY, Andonian S, Bhojani N, et al. Canadian Urological Association guideline: management of ureteral calculi - full-text. Can Urol Assoc J. 2021 Dec;15(12):E676-90.Full text Abstract
153. American College of Radiology. ACR appropriateness criteria: radiologic management of urinary tract obstruction. 2019 [internet publication].Full text
154. Qaseem A, Dallas P, Forciea MA, et al. Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2014 Nov 4;161(9):659-67.Full text Abstract
155. Brain E, Geraghty RM, Lovegrove CE, et al. Natural history of post-treatment kidney stone fragments: a systematic review and meta-analysis. J Urol. 2021 Sep;206(3):526-38.Full text Abstract
156. Rule AD, Lieske JC, Li X, et al. The ROKS nomogram for predicting a second symptomatic stone episode. J Am Soc Nephrol. 2014 Dec;25(12):2878-86. Abstract
157. Moore SL, Cook P, de Coninck V, et al. Outcomes and long-term follow-up of patients with cystine stones: a systematic review. Curr Urol Rep. 2019 Apr 15;20(6):27. Abstract
158. National Kidney Foundation. Kidney stone diet plan and prevention. 2024 [internet publication].Full text
Comorbidities Manager reference articles
159. American College of Surgeons. Best practice guidelines: geriatric trauma management. 2023 [internet publication].Full text
160. Nickel C, Arendts G, Lucke J, et al. Silver book II: Geriatric syndromes. February 2021 [internet publication].Full text
161. American College of Surgeons Trauma Quality Programs. Best practice guidelines for acute pain management in trauma patients. November 2020.Full text
162. Shenvi C, Kennedy M, Austin CA, et al. Managing delirium and agitation in the older emergency department patient: the ADEPT tool. Ann Emerg Med. 2020 Feb;75(2):136-45.Full text Abstract
163. American Geriatrics Society Expert Panel on Postoperative Delirium in Older Adults. American Geriatrics Society abstracted clinical practice guideline for postoperative delirium in older adults. J Am Geriatr Soc. 2015 Jan;63(1):142-50. Abstract
164. Williams A, Bigham C, Marchbank A. Anaesthetic and surgical management of rib fractures. BJA Educ. 2020 Oct;20(10):332-40.Full text Abstract
165. Ferreira-Valente MA, Pais-Ribeiro JL, Jensen MP. Validity of four pain intensity rating scales. Pain. 2011 Oct;152(10):2399-404. Abstract
166. Warden V, Hurley AC, Volicer L. Development and psychometric evaluation of the Pain Assessment in Advanced Dementia (PAINAD) scale. J Am Med Dir Assoc. 2003 Jan-Feb;4(1):9-15. Abstract
167. Fuchs-Lacelle S, Hadjistavropoulos T. Development and preliminary validation of the pain assessment checklist for seniors with limited ability to communicate (PACSLAC). Pain Manag Nurs. 2004 Mar;5(1):37-49. Abstract
168. Husebo BS, Strand LI, Moe-Nilssen R, et al. Pain in older persons with severe dementia: psychometric properties of the Mobilization-Observation-Behaviour-Intensity-Dementia (MOBID-2) pain scale in a clinical setting. Scand J Caring Sci. 2010 Jun;24(2):380-91. Abstract
169. The 2023 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023 Jul;71(7):2052-81.Full text Abstract
170. Dowell D, Ragan KR, Jones CM, et al. CDC cinical practice guideline for prescribing opioids for pain - United States, 2022. MMWR Recomm Rep. 2022 Nov 4;71(3):1-95.Full text Abstract
171. Owsiany MT, Hawley CE, Triantafylidis LK, et al. Opioid management in older adults with chronic kidney disease: a review. Am J Med. 2019 Dec;132(12):1386-93.Full text Abstract
172. Odoma VA, Pitliya A, AlEdani E, et al. Opioid prescription in patients with chronic kidney disease: a systematic review of comparing safety and efficacy of opioid use in chronic kidney disease patients. Cureus. 2023 Sep;15(9):e45485.Full text Abstract
173. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024 Apr;105(4s):S117-314.Full text Abstract
174. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 May 3;145(18):e895-1032.Full text Abstract
175. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021 Sep 21;42(36):3599-726.Full text Abstract
176. Global Initiative for Asthma. Global strategy for asthma management and prevention. 2024 [internet publication].Full text
177. Verbrugge FH, Grieten L, Mullens W. Management of the cardiorenal syndrome in decompensated heart failure. Cardiorenal Med. 2014 Dec;4(3-4):176-88.Full text Abstract
178. Hollenberg SM, Warner Stevenson L, Ahmad T, et al. 2019 ACC expert consensus decision pathway on risk assessment, management, and clinical trajectory of patients hospitalized with heart failure: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2019 Oct 15;74(15):1966-2011.Full text Abstract
179. Kanwar MK, Billia F, Randhawa V, et al. Heart failure related cardiogenic shock: an ISHLT consensus conference content summary. J Heart Lung Transplant. 2024 Feb;43(2):189-203.Full text Abstract
180. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012 Mar;2(1):1-138.Full text
181. Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005 Aug 30;173(5):489-95.Full text Abstract
182. Church S, Rogers E, Rockwood K, et al. A scoping review of the Clinical Frailty Scale. BMC Geriatr. 2020 Oct 7;20(1):393.Full text Abstract
183. Rockwood K, Theou O. Using the clinical frailty ccale in allocating scarce health care resources. Can Geriatr J. 2020 Sep;23(3):210-5.Full text Abstract
184. Miller RK, Young M, Chippendale R, et al. Using the Geriatric 5Ms to teach structural and social determinants of health. J Am Geriatr Soc. 2023 Dec;71(12):3967-72. Abstract
185. Molnar F, Frank CC. Optimizing geriatric care with the GERIATRIC 5Ms. Can Fam Physician. 2019 Jan;65(1):39.Full text Abstract
186. Tinetti M, Huang A, Molnar F. The Geriatrics 5M's: a new way of communicating what we do. J Am Geriatr Soc. 2017 Sep;65(9):2115.Full text Abstract
187. Jamshed N, Gangavati A. Prioritizing the 5Ms in geriatric care: a holistic approach to care of the older adult. Am Fam Physician. 2024 Jun;109(6):498-500.Full text Abstract
188. American Diabetes Association Professional Practice Committee. 16. Diabetes care in the hospital: standards of care in diabetes - 2024. Diabetes Care. 2024 Jan 1;47(suppl 1):S295-306.Full text Abstract
189. Blonde L, Umpierrez GE, Reddy SS, et al. American Association of Clinical Endocrinology clinical practice guideline: developing a diabetes mellitus comprehensive care plan - 2022 update. Endocr Pract. 2022 Oct;28(10):923-1049.Full text Abstract
190. US Food and Drug Administration. FDA revises labels of SGLT2 inhibitors for diabetes to include warnings about too much acid in the blood and serious urinary tract infections. March 2022 [internet publication].Full text
191. Umpierrez GE, Davis GM, ElSayed NA, et al. Hyperglycaemic crises in adults with diabetes: a consensus report. Diabetologia. 2024 Aug;67(8):1455-79.Full text Abstract
192. Honarmand K, Sirimaturos M, Hirshberg EL, et al. Society of Critical Care Medicine guidelines on glycemic control for critically ill children and adults 2024. Crit Care Med. 2024 Apr 1;52(4):e161-81.Full text Abstract
193. Joint British Diabetes Societies for Inpatient Care. The use of variable rate intravenous insulin infusion (VRIII) in medical inpatients. October 2014 [internet publication].Full text
194. Lim Y, Ohn JH, Jeong J, et al. Effect of the concomitant use of subcutaneous basal insulin and intravenous insulin infusion in the treatment of severe hyperglycemic patients. Endocrinol Metab (Seoul). 2022 Jun;37(3):444-54.Full text Abstract
195. Thammakosol K, Sriphrapradang C. Effectiveness and safety of early insulin glargine administration in combination with continuous intravenous insulin infusion in the management of diabetic ketoacidosis: a randomized controlled trial. Diabetes Obes Metab. 2023 Mar;25(3):815-22. Abstract
196. Korytkowski MT, Muniyappa R, Antinori-Lent K, et al. Management of hyperglycemia in hospitalized adult patients in non-critical care settings: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2022 Jul 14;107(8):2101-28.Full text Abstract
197. Grunberger G, Sherr J, Allende M, et al. American Association of Clinical Endocrinology clinical practice guideline: the use of advanced technology in the management of persons with diabetes mellitus. Endocr Pract. 2021 Jun;27(6):505-37.Full text Abstract
198. Galindo RJ, Umpierrez GE, Rushakoff RJ, et al. Continuous glucose monitors and automated insulin dosing systems in the hospital consensus guideline. J Diabetes Sci Technol. 2020 Nov;14(6):1035-64.Full text Abstract
199. Avari P, Lumb A, Flanagan D, et al. Insulin pumps and hybrid close loop systems within hospital: a scoping review and practical guidance from the Joint British Diabetes Societies for Inpatient Care. J Diabetes Sci Technol. 2023 May;17(3):625-34.Full text Abstract
200. Peters AL, Buschur EO, Buse JB, et al. Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition. Diabetes Care. 2015 Sep;38(9):1687-93.Full text Abstract
201. Umapathysivam MM, Gunton J, Stranks SN, et al. Euglycemic ketoacidosis in two patients without diabetes after introduction of sodium-glucose cotransporter 2 inhibitor for heart failure with reduced ejection fraction. Diabetes Care. 2024 Jan 1;47(1):140-3.Full text Abstract
202. Duggan EW, Carlson K, Umpierrez GE. Perioperative hyperglycemia management: an update. Anesthesiology. 2017 Mar;126(3):547-60.Full text Abstract
203. Joshi GP, Abdelmalak BB, Weigel WA et al. American Society of Anaesthesiologists consensus-based guidance on preoperative management of patients (adults and children) on glucagon-like peptide-1 (glp-1) receptor agonists. June 2023 [internet reference].Full text
204. Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005 Apr;53(4):695-9. Abstract
205. Canadian Geriatrics Society. Update: Public launch of the geriatric 5Ms. 2017 [internet publication].Full text
206. Devlin JW, Skrobik Y, Gélinas C, et al. Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med. 2018 Sep;46(9):e825-73.Full text Abstract
207. Inouye SK, Schlesinger MJ, Lydon TJ. Delirium: a symptom of how hospital care is failing older persons and a window to improve quality of hospital care. Am J Med. 1999 May;106(5):565-73.Full text Abstract
208. Han JH, Wilson A, Vasilevskis EE, et al. Diagnosing delirium in older emergency department patients: validity and reliability of the delirium triage screen and the brief confusion assessment method. Ann Emerg Med. 2013 Nov;62(5):457-65. Abstract
209. American College of Emergency Physicians, American Geriatrics Society, Emergency Nurses Association, et al. Geriatric emergency department guidelines. Ann Emerg Med. 2014 May;63(5):e7-25.Full text Abstract
210. Inouye SK, van Dyck CH, Alessi CA, et al. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990 Dec 15;113(12):941-8. Abstract
211. Wei LA, Fearing MA, Sternberg EJ, et al. The Confusion Assessment Method: a systematic review of current usage. J Am Geriatr Soc. 2008 May;56(5):823-30. Abstract
212. Ely EW, Margolin R, Francis J, et al. Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Crit Care Med. 2001 Jul;29(7):1370-9. Abstract
213. Bergeron N, Dubois MJ, Dumont M, et al. Intensive Care Delirium Screening Checklist: evaluation of a new screening tool. Intensive Care Med. 2001 May;27(5):859-64. Abstract
214. National Institute for Health and Care Excellence. Delirium: prevention, diagnosis and management in hospital and long-term care. January 2023 [internet publication].Full text
215. Inouye SK, Bogardus ST Jr, Baker DI, et al. The Hospital Elder Life Program: a model of care to prevent cognitive and functional decline in older hospitalized patients. Hospital Elder Life Program. J Am Geriatr Soc. 2000 Dec;48(12):1697-706. Abstract
216. Hshieh TT, Yang T, Gartaganis SL, et al. Hospital Elder Life Program: systematic review and meta-analysis of effectiveness. Am J Geriatr Psychiatry. 2018 Oct;26(10):1015-33. Abstract
217. Hshieh TT, Yue J, Oh E, et al. Effectiveness of multicomponent nonpharmacological delirium interventions: a meta-analysis. JAMA Intern Med. 2015 Apr;175(4):512-20.Full text Abstract
218. Mohanty S, Rosenthal RA, Russell MM, et al. Optimal perioperative management of the geriatric patient: a best practices guideline from the American College of Surgeons NSQIP and the American Geriatrics Society. J Am Coll Surg. 2016 May;222(5):930-47. Abstract
219. White S, Griffiths R, Baxter M, et al. Guidelines for the peri-operative care of people with dementia: guidelines from the Association of Anaesthetists. Anaesthesia. 2019 Mar;74(3):357-72.Full text Abstract
220. Inouye SK, Kosar CM, Tommet D, et al. The CAM-S: development and validation of a new scoring system for delirium severity in 2 cohorts. Ann Intern Med. 2014 Apr 15;160(8):526-33.Full text Abstract
221. Burton JK, Craig L, Yong SQ, et al. Non-pharmacological interventions for preventing delirium in hospitalised non-ICU patients. Cochrane Database Syst Rev. 2021 Nov 26;(11):CD013307.Full text Abstract
222. Peden CJ, Miller TR, Deiner SG, et al. Improving perioperative brain health: an expert consensus review of key actions for the perioperative care team. Br J Anaesth. 2021 Feb;126(2):423-432.Full text Abstract
223. Nikooie R, Neufeld KJ, Oh ES, et al. Antipsychotics for treating delirium in hospitalized adults: a systematic review. Ann Intern Med. 2019 Oct 1;171(7):485-95.Full text Abstract
224. Mühlbauer V, Möhler R, Dichter MN, et al. Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia. Cochrane Database Syst Rev. 2021 Dec 17;(12):CD013304.Full text Abstract
225. Yunusa I, Alsumali A, Garba AE, et al. Assessment of reported comparative effectiveness and safety of atypical antipsychotics in the treatment of behavioral and psychological symptoms of dementia: a network meta-analysis. JAMA Netw Open. 2019 Mar 1;2(3):e190828.Full text Abstract
226. Van Leeuwen E, Petrovic M, van Driel ML, et al. Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia. Cochrane Database Syst Rev. 2018 Apr 1;(3):CD007726.Full text Abstract
227. Grau AJ, Urbanek C, Palm F. Common infections and the risk of stroke. Nat Rev Neurol. 2010 Dec;6(12):681-94. Abstract
228. Elkind MSV, Boehme AK, Smith CJ, et al. Infection as a Stroke risk factor and determinant of outcome after stroke. Stroke. 2020 Oct;51(10):3156-68.Full text Abstract
229. Eigenbrodt ML, Rose KM, Couper DJ, et al. Orthostatic hypotension as a risk factor for stroke: the atherosclerosis risk in communities (ARIC) study, 1987-1996. Stroke. 2000 Oct;31(10):2307-13.Full text Abstract
230. Winstein CJ, Stein J, Arena R, et al. Guidelines for adult stroke rehabilitation and recovery: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2016 Jun;47(6):e98-169.Full text Abstract
231. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001 Nov 8;345(19):1359-67.Full text Abstract
232. NICE-SUGAR Study Investigators; Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009 Mar 26;360(13):1283-97.Full text Abstract
233. Yamada T, Shojima N, Noma H, et al. Glycemic control, mortality, and hypoglycemia in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials. Intensive Care Med. 2017 Jan;43(1):1-15. Abstract
234. Yatabe T, Inoue S, Sakaguchi M, et al. The optimal target for acute glycemic control in critically ill patients: a network meta-analysis. Intensive Care Med. 2017 Jan;43(1):16-28. Abstract
235. Pasquel FJ, Lansang MC, Dhatariya K, et al. Management of diabetes and hyperglycaemia in the hospital. Lancet Diabetes Endocrinol. 2021 Mar;9(3):174-88.Full text Abstract
236. Rehman A, Setter SM, Vue MH. Drug-induced glucose alterations part 2: drug-Induced hyperglycemia. Diabetes Spect. 2011 Nov;24(4):234-8.Full text
237. American Diabetes Association Professional Practice Committee. 6. Glycemic goals and hypoglycemia: standards of care in diabetes - 2024. Diabetes Care. 2024 Jan 1;47(suppl 1):S111-25.Full text Abstract
238. Vue MH, Setter SM. Drug-Induced Glucose Alterations Part 1: Drug-Induced Hypoglycemia. Diabetes Spectr 1 August 2011; 24 (3): 171–7.Full text Abstract
239. Wang C, Fang W, Li Z, et al. Clinical features, risk factors, diagnosis, and treatment of trimethoprim-sulfamethoxazole-induced hypoglycemia. Front Endocrinol (Lausanne). 2023;14:1059522.Full text Abstract
240. McCall AL, Lieb DC, Gianchandani R, et al. Management of individuals with diabetes at high risk for hypoglycemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2023 Feb 15;108(3):529-62.Full text Abstract
241. National Institute for Health and Care Excellence. Diabetic foot problems: prevention and management. October 2019 [internet publication].Full text
242. American Diabetes Association Professional Practice Committee. 12. Retinopathy, neuropathy, and foot care: standards of care in diabetes - 2024. Diabetes Care. 2024 Jan 1;47(suppl 1):S231-43.Full text Abstract
243. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2024 [internet publication].Full text
244. Salpeter SR, Ormiston TM, Salpeter EE. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. Chest. 2004 Jun;125(6):2309-21. Abstract
245. Au DH, Curtis JR, Every NR, et al. Association between inhaled beta-agonists and the risk of unstable angina and myocardial infarction. Chest. 2002 Mar;121(3):846-51. Abstract
246. US Preventive Services Task Force, Krist AH, Davidson KW, et al. Interventions for tobacco smoking cessation in adults, including pregnant persons: US Preventive Services Task Force recommendation statement. JAMA. 2021 Jan 19;325(3):265-79.Full text Abstract
247. Fiore MC, Jaén CR, Baker TB, et al. Treating tobacco use and dependence: 2008 update. Clinical practice guideline. Rockville, MD: US Department of Health and Human Services Public Health Service; May 2008 [internet publication].Full text
248. United States Public Health Service Office of the Surgeon General, National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. Smoking cessation: a report of the Surgeon General. Washington, DC: US Department of Health and Human Services; 2020 [internet publication].Full text Abstract
249. Streck JM, Rigotti NA, Livingstone-Banks J, et al. Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev. 2024 May 21;(5):CD001837.Full text Abstract
250. Theodoulou A, Chepkin SC, Ye W, et al. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2023 Jun 19;(6):CD013308.Full text Abstract
251. Rigotti NA, Kruse GR, Livingstone-Banks J, et al. Treatment of tobacco smoking: a review. JAMA. 2022 Feb 8;327(6):566-77. Abstract
252. Agrawal S, Evison M, Ananth S, et al. Medical management of inpatients with tobacco dependency. Thorax. 2024 Mar 26;79(suppl 1):3-11. Abstract
253. Thomas KH, Dalili MN, López-López JA, et al. Comparative clinical effectiveness and safety of tobacco cessation pharmacotherapies and electronic cigarettes: a systematic review and network meta-analysis of randomized controlled trials. Addiction. 2022 Apr;117(4):861-76.Full text Abstract
254. Livingstone-Banks J, Fanshawe TR, Thomas KH, et al. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2023 Jun 28;(6):CD006103.Full text
255. Perret J, Yip SWS, Idrose NS, et al. Undiagnosed and 'overdiagnosed' COPD using postbronchodilator spirometry in primary healthcare settings: a systematic review and meta-analysis. BMJ Open Respir Res. 2023 Apr;10(1):e001478.Full text Abstract
256. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13.Full text Abstract
257. Silverman JJ, Galanter M, Jackson-Triche M, et al. The American Psychiatric Association practice guidelines for the psychiatric evaluation of adults. Am J Psychiatry. 2015 Aug 1;172(8):798-802.Full text Abstract
258. Boden JM, Fergusson DM. Alcohol and depression. Addiction. 2011 May;106(5):906-14. Abstract
259. Bauer M, Severus E, Köhler S, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. part 2: maintenance treatment of major depressive disorder-update 2015. World J Biol Psychiatry. 2015 Feb;16(2):76-95. Abstract
260. Hoffelt C, Gross T. A review of significant pharmacokinetic drug interactions with antidepressants and their management. Ment Health Clin. 2016 Mar 8;6(1):35-41.Full text Abstract
261. Van Leeuwen E, van Driel ML, Horowitz MA, et al. Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults. Cochrane Database Syst Rev. 2021 Apr 15;(4):CD013495.Full text Abstract
262. Qaseem A, Owens DK, Etxeandia-Ikobaltzeta I, et al. Nonpharmacologic and pharmacologic treatments of adults in the acute phase of major depressive disorder: a living clinical guideline from the American College of Physicians. Ann Intern Med. 2023 Feb;176(2):239-52.Full text Abstract
263. Liamis G, Milionis H, Elisaf M. A review of drug-induced hyponatremia. Am J Kidney Dis. 2008 Jul;52(1):144-53. Abstract
264. Liamis G, Filippatos TD, Elisaf MS. Thiazide-associated hyponatremia in the elderly: what the clinician needs to know. J Geriatr Cardiol. 2016 Feb;13(2):175-82.Full text Abstract
265. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005 Mar 17;352(11):1112-20. Abstract
266. Buckley NA, Dawson AH, Isbister GK. Serotonin syndrome. BMJ. 2014 Feb 19;348:g1626. Abstract
267. Volpi-Abadie J, Kaye AM, Kaye AD. Serotonin syndrome. Ochsner J. 2013 Winter;13(4):533-40.Full text Abstract
268. Chander WP, Singh N, Mukhiya GK. Serotonin syndrome in maintenance haemodialysis patients following sertraline treatment for depression. J Indian Med Assoc. 2011 Jan;109(1):36-7. Abstract
269. Voican CS, Corruble E, Naveau S, et al. Antidepressant-induced liver injury: a review for clinicians. Am J Psychiatry. 2014 Apr;171(4):404-15.Full text Abstract
270. Saraghi M, Golden LR, Hersh EV. Anesthetic considerations for patients on antidepressant therapy-part I. Anesth Prog. 2017 Winter;64(4):253-61.Full text Abstract
271. Harbell MW, Dumitrascu C, Bettini L, et al. Anesthetic considerations for patients on psychotropic drug therapies. Neurol Int. 2021 Nov 29;13(4):640-58.Full text Abstract
272. Tisdale JE, Chung MK, Campbell KB, et al. Drug-induced arrhythmias: a scientific statement from the American Heart Association. Circulation. 2020 Oct 13;142(15):e214-233.Full text Abstract
273. Siu AL, US Preventive Services Task Force (USPSTF), Bibbins-Domingo K, et al. Screening for depression in adults: US Preventive Services Task Force recommendation statement. JAMA. 2016 Jan 26;315(4):380-7.Full text Abstract
274. Halperin D, Reber G. Influence of antidepressants on hemostasis. Dialogues Clin Neurosci. 2007;9(1):47-59.Full text Abstract
275. Nochaiwong S, Ruengorn C, Awiphan R, et al. Use of serotonin reuptake inhibitor antidepressants and the risk of bleeding complications in patients on anticoagulant or antiplatelet agents: a systematic review and meta-analysis. Ann Med. 2022 Dec;54(1):80-97.Full text Abstract
276. Loke YK, Trivedi AN, Singh S. Meta-analysis: gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther. 2008 Jan 1;27(1):31-40.Full text Abstract
277. Flowers L. Nicotine replacement therapy. Am J Psychiatry Resid J. 2016 Jun;11(6):4-7.Full text
278. Desai HD, Seabolt J, Jann MW. Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective. CNS Drugs. 2001;15(6):469-94. Abstract
279. Oliveira P, Ribeiro J, Donato H, et al. Smoking and antidepressants pharmacokinetics: a systematic review. Ann Gen Psychiatry. 2017 Mar 6:16:17.Full text Abstract
280. Saraghi M, Golden L, Hersh EV. Anesthetic considerations for patients on antidepressant therapy - part II. Anesth Prog. 2018 Spring;65(1):60-5.Full text Abstract
281. Roose SP, Rutherford BR. Selective serotonin reuptake inhibitors and operative bleeding risk: a review of the literature. J Clin Psychopharmacol. 2016 Dec;36(6):704-9. Abstract
282. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000 Jul 24;160(14):2101-7.Full text Abstract
283. Lapa ME, Swabe GM, Rollman BL, et al. Assessment of depression and adherence to guideline-directed medical therapies following percutaneous coronary intervention. JAMA Netw Open. 2022 Dec 1;5(12):e2246317.Full text Abstract
284. Poletti V, Pagnini F, Banfi P, et al. The role of depression on treatment adherence in patients with heart failure-a systematic review of the literature. Curr Cardiol Rep. 2022 Dec;24(12):1995-2008.Full text Abstract
285. Prina AM, Cosco TD, Dening T, et al. The association between depressive symptoms in the community, non-psychiatric hospital admission and hospital outcomes: a systematic review. J Psychosom Res. 2015 Jan;78(1):25-33.Full text Abstract
286. Clarke DM, Currie KC. Depression, anxiety and their relationship with chronic diseases: a review of the epidemiology, risk and treatment evidence. Med J Aust. 2009 Apr 6;190(s7):S54-60.Full text Abstract
Use of this content is subject to our disclaimer